Cargando…
Clinical Use of Colistin Induces Cross-Resistance to Host Antimicrobials in Acinetobacter baumannii
The alarming rise in antibiotic resistance has led to an increase in patient mortality and health care costs. This problem is compounded by the absence of new antibiotics close to regulatory approval. Acinetobacter baumannii is a human pathogen that causes infections primarily in patients in intensi...
Autores principales: | Napier, Brooke A., Burd, Eileen M., Satola, Sarah W., Cagle, Stephanie M., Ray, Susan M., McGann, Patrick, Pohl, Jan, Lesho, Emil P., Weiss, David S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Microbiology
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3663567/ https://www.ncbi.nlm.nih.gov/pubmed/23695834 http://dx.doi.org/10.1128/mBio.00021-13 |
Ejemplares similares
-
Carbapenem-Resistant Klebsiella pneumoniae Exhibiting Clinically Undetected Colistin Heteroresistance Leads to Treatment Failure in a Murine Model of Infection
por: Band, Victor I., et al.
Publicado: (2018) -
In Vivo Fitness Adaptations of Colistin-Resistant Acinetobacter baumannii Isolates to Oxidative Stress
por: Jones, Crystal L., et al.
Publicado: (2017) -
Identification of Novel Acinetobacter baumannii Host Fatty Acid Stress Adaptation Strategies
por: Jiang, Jhih-Hang, et al.
Publicado: (2019) -
Colistin Heteroresistance Is Largely Undetected among Carbapenem-Resistant Enterobacterales in the United States
por: Band, Victor I., et al.
Publicado: (2021) -
Identification of an Outbreak Cluster of Extensively Antibiotic-Resistant GC1 Acinetobacter baumannii Isolates in U.S. Military Treatment Facilities
por: Luo, Ting L., et al.
Publicado: (2023)